Home
TRVI
TRVI News

Latest Trevi Therapeutics Inc. (TRVI) News on September 7, 2024

Trevi Therapeutics Announces Oral Presentation on Data from Ph2a CANAL Trial at the European Respiratory Society Congress 2024

PR Newswire

3 days ago

Trevi Therapeutics Announces Oral Presentation on Data from Ph2a CANAL Trial at the European Respiratory Society Congress 2024

Abercrombie upgraded, Dollar General downgraded: Wall Street's top analyst calls

The Fly

8 days ago

Abercrombie upgraded, Dollar General downgraded: Wall Street's top analyst calls

MT Newswires

9 days ago

Raymond James Starts Trevi Therapeutics With Outperform Rating

MT Newswires

9 days ago

HC Wainwright Initiates Trevi Therapeutics at Buy

Trevi Therapeutics to Participate in September Investor and Medical Conferences

PR Newswire

11 days ago

Trevi Therapeutics to Participate in September Investor and Medical Conferences

Trevi Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates Reaffirming Clinical Trial Guidance

PR Newswire

a month ago

Trevi Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates Reaffirming Clinical Trial Guidance

Institutional investors in Trevi Therapeutics, Inc. (NASDAQ:TRVI) see US$40m decrease in market cap last week, although long-term gains have benefitted them.

Simply Wall St.

a month ago

Institutional investors in Trevi Therapeutics, Inc. (NASDAQ:TRVI) see US$40m decrease in market cap last week, although long-term gains have benefitted them.

Trevi Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 8, 2024

PR Newswire

a month ago

Trevi Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 8, 2024

Trevi Therapeutics to Participate in Upcoming Investor and Healthcare Events

PR Newswire

2 months ago

Trevi Therapeutics to Participate in Upcoming Investor and Healthcare Events

Here's Why We're Not Too Worried About Trevi Therapeutics' (NASDAQ:TRVI) Cash Burn Situation

Simply Wall St.

2 months ago

Here's Why We're Not Too Worried About Trevi Therapeutics' (NASDAQ:TRVI) Cash Burn Situation

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q1 2024 Earnings Call Transcript

Insider Monkey

4 months ago

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q1 2024 Earnings Call Transcript

Trevi Therapeutics to Participate in Upcoming Conferences

PR Newswire

4 months ago

Trevi Therapeutics to Participate in Upcoming Conferences

Thomson Reuters StreetEvents

4 months ago

Q1 2024 Trevi Therapeutics Inc Earnings Call

GuruFocus.com

4 months ago

Trevi Therapeutics Reports Q1 2024 Financial Results: A Detailed Analysis

Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

PR Newswire

4 months ago

Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

Trevi Therapeutics to Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 7, 2024

PR Newswire

4 months ago

Trevi Therapeutics to Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 7, 2024

Trevi Therapeutics (TRVI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Zacks

5 months ago

Trevi Therapeutics (TRVI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International Conference

PR Newswire

5 months ago

Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International Conference

Why Trevi Therapeutics (TRVI) Stock Might be a Great Pick

Zacks

5 months ago

Why Trevi Therapeutics (TRVI) Stock Might be a Great Pick

Trevi Therapeutics to Participate in Upcoming April Events

PR Newswire

5 months ago

Trevi Therapeutics to Participate in Upcoming April Events

Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Team

PR Newswire

5 months ago

Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Team

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q4 2023 Earnings Call Transcript

Insider Monkey

6 months ago

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q4 2023 Earnings Call Transcript

GuruFocus.com

6 months ago

Trevi Therapeutics Inc (TRVI) Announces Year-End Financials and Progress in Clinical Trials

Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Updates

PR Newswire

6 months ago

Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Updates

Trevi Therapeutics to Report Q4 and Year End 2023 Financial Results and Provide a Corporate Update on March 20, 2024

PR Newswire

6 months ago

Trevi Therapeutics to Report Q4 and Year End 2023 Financial Results and Provide a Corporate Update on March 20, 2024

private equity firms who own 35% along with institutions invested in Trevi Therapeutics, Inc. (NASDAQ:TRVI) saw increase in their holdings value last week

Simply Wall St.

6 months ago

private equity firms who own 35% along with institutions invested in Trevi Therapeutics, Inc. (NASDAQ:TRVI) saw increase in their holdings value last week

Trevi Therapeutics to Participate in Upcoming March Events

PR Newswire

6 months ago

Trevi Therapeutics to Participate in Upcoming March Events

Trevi Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

PR Newswire

7 months ago

Trevi Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Fisker Welcomes Dealers From Across North America to Its First Open House and Signs First US Dealer Partner

Business Wire

7 months ago

Fisker Welcomes Dealers From Across North America to Its First Open House and Signs First US Dealer Partner

Planet Image International Limited Announces Closing of $5 Million Initial Public Offering

PR Newswire

7 months ago

Planet Image International Limited Announces Closing of $5 Million Initial Public Offering

Chemung Financial Corporation (NASDAQ:CHMG) Analysts Are Pretty Bullish On The Stock After Recent Results

Simply Wall St.

7 months ago

Chemung Financial Corporation (NASDAQ:CHMG) Analysts Are Pretty Bullish On The Stock After Recent Results

With 30% stake, 1stdibs.Com, Inc. (NASDAQ:DIBS) seems to have captured institutional investors' interest

Simply Wall St.

7 months ago

With 30% stake, 1stdibs.Com, Inc. (NASDAQ:DIBS) seems to have captured institutional investors' interest

A Closer Look At Planet Image International Limited's (NASDAQ:YIBO) Impressive ROE

Simply Wall St.

7 months ago

A Closer Look At Planet Image International Limited's (NASDAQ:YIBO) Impressive ROE

Crexendo(R) Breaks Records with Outstanding 36% User Surge in 2023 - Nearly Double the Industry Average, Wins Frost & Sullivan Leadership Award

ACCESSWIRE

7 months ago

Crexendo(R) Breaks Records with Outstanding 36% User Surge in 2023 - Nearly Double the Industry Average, Wins Frost & Sullivan Leadership Award

We're Not Very Worried About Trevi Therapeutics' (NASDAQ:TRVI) Cash Burn Rate

Simply Wall St.

8 months ago

We're Not Very Worried About Trevi Therapeutics' (NASDAQ:TRVI) Cash Burn Rate

Trevi Therapeutics, Inc. (TRVI) Upgraded to Strong Buy: Here's Why

Zacks

8 months ago

Trevi Therapeutics, Inc. (TRVI) Upgraded to Strong Buy: Here's Why

Allurion's Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic Partnerships

Business Wire

8 months ago

Allurion's Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic Partnerships

Here's Why Bank7 (NASDAQ:BSVN) Has Caught The Eye Of Investors

Simply Wall St.

8 months ago

Here's Why Bank7 (NASDAQ:BSVN) Has Caught The Eye Of Investors

Ambrx Snags $2 Billion Takeover, But CEO Dan O'Connor Says Don't Call It 'Hot'

Investor's Business Daily

8 months ago

Ambrx Snags $2 Billion Takeover, But CEO Dan O'Connor Says Don't Call It 'Hot'

AMTD IDEA Awarded "Best Financial Services" Recognition

Business Wire

8 months ago

AMTD IDEA Awarded "Best Financial Services" Recognition

Trevi Therapeutics Provides Business Updates

PR Newswire

8 months ago

Trevi Therapeutics Provides Business Updates

Modiv Industrial, Inc.'s (NYSE:MDV) Path To Profitability

Simply Wall St.

8 months ago

Modiv Industrial, Inc.'s (NYSE:MDV) Path To Profitability

20 Most Luxurious and Expensive Woods for Furniture In The World

Insider Monkey

8 months ago

20 Most Luxurious and Expensive Woods for Furniture In The World

Gold Royalty Completes Acquisition of Québec Royalty Portfolio

CNW Group

9 months ago

Gold Royalty Completes Acquisition of Québec Royalty Portfolio

RADCOM Ltd. (NASDAQ:RDCM) most popular amongst retail investors who own 37% of the shares, institutions hold 23%

Simply Wall St.

9 months ago

RADCOM Ltd. (NASDAQ:RDCM) most popular amongst retail investors who own 37% of the shares, institutions hold 23%

Eltek placed purchase orders for $4.5 million in connection with the expansion of its production capabilities.

PR Newswire

9 months ago

Eltek placed purchase orders for $4.5 million in connection with the expansion of its production capabilities.

Western New England Bancorp's (NASDAQ:WNEB) investors will be pleased with their favorable 33% return over the last three years

Simply Wall St.

9 months ago

Western New England Bancorp's (NASDAQ:WNEB) investors will be pleased with their favorable 33% return over the last three years

CNW Group

9 months ago

Canadian Investment Regulatory Organization Trading Halt - MMED.WA

Inogen (INGN) Down 4.2% Since Last Earnings Report: Can It Rebound?

Zacks

9 months ago

Inogen (INGN) Down 4.2% Since Last Earnings Report: Can It Rebound?

Trevi Therapeutics Announces the Initiation of its Phase 2b CORAL Clinical Trial of Haduvio™ for Chronic Cough in Idiopathic Pulmonary Fibrosis (IPF)

PR Newswire

9 months ago

Trevi Therapeutics Announces the Initiation of its Phase 2b CORAL Clinical Trial of Haduvio™ for Chronic Cough in Idiopathic Pulmonary Fibrosis (IPF)

Down -38.07% in 4 Weeks, Here's Why You Should You Buy the Dip in Trevi Therapeutics, Inc. (TRVI)

Zacks

9 months ago

Down -38.07% in 4 Weeks, Here's Why You Should You Buy the Dip in Trevi Therapeutics, Inc. (TRVI)

Investing in William Penn Bancorporation (NASDAQ:WMPN) five years ago would have delivered you a 29% gain

Simply Wall St.

9 months ago

Investing in William Penn Bancorporation (NASDAQ:WMPN) five years ago would have delivered you a 29% gain

2 of the Cheapest Stocks I Own

Motley Fool

10 months ago

2 of the Cheapest Stocks I Own

iTeos to Present at the Piper Sandler 35th Annual Healthcare Conference

GlobeNewswire

10 months ago

iTeos to Present at the Piper Sandler 35th Annual Healthcare Conference

Trevi Therapeutics, Inc. (TRVI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Zacks

10 months ago

Trevi Therapeutics, Inc. (TRVI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

After Plunging -28.72% in 4 Weeks, Here's Why the Trend Might Reverse for Trevi Therapeutics, Inc. (TRVI)

Zacks

10 months ago

After Plunging -28.72% in 4 Weeks, Here's Why the Trend Might Reverse for Trevi Therapeutics, Inc. (TRVI)

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q3 2023 Earnings Call Transcript

Insider Monkey

10 months ago

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q3 2023 Earnings Call Transcript

GH Research Reports Third Quarter Financial Results and Provides Business Updates

GlobeNewswire

10 months ago

GH Research Reports Third Quarter Financial Results and Provides Business Updates

Outset Medical to Present at Upcoming Investor Conferences

Business Wire

10 months ago

Outset Medical to Present at Upcoming Investor Conferences

InfuSystem Reports Third Quarter 2023 Financial Results

Business Wire

10 months ago

InfuSystem Reports Third Quarter 2023 Financial Results

Artesian Resources Corporation Reports Third Quarter and Year-To-Date 2023 Results

GlobeNewswire

10 months ago

Artesian Resources Corporation Reports Third Quarter and Year-To-Date 2023 Results

MindMed Reports Third Quarter 2023 Financial Results and Business Highlights

Business Wire

10 months ago

MindMed Reports Third Quarter 2023 Financial Results and Business Highlights

Share on Social Networks: